Innate Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Innate Pharma and buy or sell other stocks, ETFs, and their options commission-free!About IPHA
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62.
CEOJonathan Dickinson
CEOJonathan Dickinson
Employees—
Employees—
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded1999
Founded1999
Employees—
Employees—
IPHA Key Statistics
Market cap130.31M
Market cap130.31M
Price-Earnings ratio-2.17
Price-Earnings ratio-2.17
Dividend yield—
Dividend yield—
Average volume26.74K
Average volume26.74K
High today$1.40
High today$1.40
Low today$1.33
Low today$1.33
Open price$1.33
Open price$1.33
Volume17.15K
Volume17.15K
52 Week high$2.63
52 Week high$2.63
52 Week low$1.17
52 Week low$1.17
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.